Monthly Archives: January 2021

Board IPR FWD finding Sanofi’s amended claims not unpatentable affirmed

Mylan Laboratories Limited v. Aventis Pharma S.A. Docket No. 2020-1302 (IPR2016-00712) ( NEWMAN, O’MALLEY, WALLACH January 15, 2020 Brief Summary:  FC panel affirmed Board IPR FWD finding Sanofi’s amended claims not to be unpatentable for obviousness, public use and section … Continue reading

Posted in Anticipation (35 USC 102), Claim Construction, Inter Parties Review (IPR), IPR, Obviousness, Patent Eligibility (101), Public Use | Leave a comment

DC grant of SJ to SIMO reversed without remand due to improper construction of preamble

SIMO Holdings Inc. v. Hong Kong uCloudlink et al. Docket No. 2019-2411 ( O’MALLEY, WALLACH, TARANTO January 5, 2021 Brief Summary:  DC claim construction and grant of SJ to SIMO reversed due to improper interpretation of preamble language. Summary:  uCloud … Continue reading

Posted in Claim Construction, Infringement, Preamble | Leave a comment

“Substantial risk of future infringement” provides standing for IPR appeal; non-obviousness conclusion vacated and remanded

General Electric Company v. Raytheon Technologies Corporation Docket No. 2019-1319 (IPR2017-00428) ( LOURIE, REYNA, HUGHES December 23, 2020 Brief Summary:  GE found to have standing due to a substantial risk of future infringement”; Board finding of no obviousness vacated and … Continue reading

Posted in Appeal, Obviousness, Obviousness-Teaching Away, Uncategorized | Leave a comment